We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QSI:NASDAQQuantum-Si Incorporated analysis

Data as of Oct 22, 2026 - not real-time

Latest price
$1.15
Risk: high
9/10High risk

Summary

Quantum-Si incorporated trades at $1.15, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 55.6%. RSI sits at 51.0, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $0.7760 and resistance at $1.66.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Analyst price targets sit 98.6% above the current price. Revenue is contracting at 41.8%.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 160.5%, a beta of 3.41 and a maximum drawdown of 70.0%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 87 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 1 out of 10.

Top market events

  • QSI reported USD 344,000 in second-quarter revenue, down 41.
  • Quantum-Si Incorporated stocks have been trading up by 9.
  • BRANFORD, Conn., Sept. 15, 2026 GLOBE NEWSWIRE -- Quantum-Si Incorporated Nasdaq: QSI "Quantum-Si," "QSI" or the...

Market outlook

Short term

< 1 year

Neutral

Model confidence1/101 out of 10

Key factors

  • Trading above the 200-day average of 0.95
  • MACD momentum is negative
  • 30-day price change of +55.6%

Medium term

1–3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Trading above the 200-day average of 0.95
  • Analyst targets imply +98.6% versus the current price
  • 30-day volatility of 160.5%

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • Analyst targets imply +98.6% versus the current price
  • Negative return on equity of -49.1%
  • Revenue contracting at -41.8%

Key metrics

Financial health

Revenue Growth-41.80%
P/E Ratio-3.3
ROE-49.11%
ROA-25.71%
Debt/Equity1.80
P/B Ratio1.4
Op. Cash Flow$-92448000
Free Cash Flow$-50126000
Industry P/E32.3

Technical analysis

TrendNeutral
RSI51.0
Support$0.78
Resistance$1.66
MA 20$1.22
MA 50$0.95
MA 200$0.95
MACDBearish
VolumeDecreasing
Fear & Greed Index87.45

Valuation

Target Price$2.28
Upside/Downside98.55%
GradeFair
TypeBlend

Risk assessment

Beta3.41
Volatility160.48%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.